Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines.
about
Acellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenMolecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Concerns about immunisationPertussis vaccine trials in the 1990sThe US Food and Drug Administration provides a pathway for licensing vaccines for global diseasesPertussis: Microbiology, Disease, Treatment, and Prevention.British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.Human immunity and the design of multi-component, single target vaccines.Bordetella pertussis isolates in Finland: serotype and fimbrial expressionProduction and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.Acellular pertussis vaccine efficacy: An updated systematic review and meta -analysis.Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programsAnalysis of Bordetella pertussis populations in European countries with different vaccination policiesProtective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge modelComparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussisAcellular pertussis vaccines and the role of pertactin and fimbriae.A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old childrenPertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccinePertussis immunization in infancy and adolescent asthma medicationPertussis re-emergence in the post-vaccination eraPertussis vaccine: a critique.Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.Pertussis is increasing in unimmunized infants: is a change in policy needed?Acellular pertussis vaccine given by accelerated schedule: response of preterm infantsCharacterization of co-purified acellular pertussis vaccines.
P2860
Q24193554-EAA773EF-2D6D-4BAA-954D-BD99D093664BQ24201103-70DCD92C-9036-4ECD-9864-A5A36A939CE2Q24234899-A6FF63D3-5302-47FC-ABBF-CFE2BC5A5BBBQ24243261-DC9CA441-B0C9-4940-983B-32A7924AFCA2Q24522458-2DE8C82D-9B72-4869-85AC-5D5C565390C8Q24524552-8FB3699E-41D7-4A30-9A3C-91171E1C98CCQ27025393-C537B7E9-5857-41F7-8343-9045BEB514F2Q28475743-CD0C386B-0A28-4FD7-B7F6-72C0C7E92DB2Q30251684-A2525B36-E23A-46F8-BF95-46EA8ACCADFEQ30478714-3BF5612D-944F-4BB5-9B4F-BCC304F67029Q33297012-09B6E8E7-4DB3-456B-8BFD-2B64B955C7BDQ33371827-F26F97E5-546F-46D3-BB6A-592A2469C587Q33521111-11C570EF-E5A5-484D-AFB4-3057BD121243Q33564283-4EF4DF69-D57F-42D7-82F3-9FDB0000A85BQ33642326-2DD2D6C9-2F3F-40ED-A814-C0FA4D46E54EQ33738499-74F756BA-5E3E-4398-B815-B5797BB05308Q33750257-1C498493-E1EF-4F8C-B00E-784D1554AED3Q33769972-B62503C6-A717-49BB-8F19-C9272067F0C0Q33825642-D6D3D4B9-1398-492E-958A-C6A856DAD457Q33856133-C7C72B17-8A38-4D4B-A8A1-1947D405BB0BQ33856228-B99D66E9-BD5E-403D-9894-D7D3B861F654Q33866775-152E0AD2-EB4B-4B2D-9FF5-A8A10898DC57Q33998364-02D3542A-2629-454F-BB6C-104FAFF705D6Q34002283-0179CA82-3553-4ECB-ADB3-67D1416F95D5Q34003563-FD8BA112-4905-472E-AD97-09438A77BA6DQ34008022-9A63DF3B-5590-42CF-90E2-85516002E57CQ34008317-FE4E5D2F-7031-40ED-A7F4-ED748CDC7FC4Q34126969-3239FC53-4532-4BF1-9795-21E4EBB6C30AQ34129001-39378C50-6360-45FD-993A-6697CA73416FQ34163792-113D18AA-F5DD-4BF4-AB88-3557856F7255Q34194621-56D493FA-545B-4FC0-B886-C84E49E0C66DQ34260834-9E87018D-1D9F-451B-8EFB-D16F606D39A7Q34263129-03035F0C-5DCB-4F9A-AB17-80DA35736FA1Q34636630-E59FAFF4-73A2-4AC9-A69C-C48119640CEAQ34657980-575ACAEE-D03B-4CE4-8DAB-01CE9989C935Q34671882-035419F5-6BD2-4856-9EA3-780FA4BB458DQ35220336-78B1BF19-C1D1-49E4-9296-F160C850FE40Q35262619-51EE801F-3261-4516-A278-A05A051CDB3FQ35294220-FFE6BB0B-E66A-4C61-8A13-BE39CBC91082Q35887534-393EB582-2CD6-43C9-896C-91A2F158E555
P2860
Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Randomised controlled trial of ...... e Study of Pertussis Vaccines.
@en
type
label
Randomised controlled trial of ...... e Study of Pertussis Vaccines.
@en
prefLabel
Randomised controlled trial of ...... e Study of Pertussis Vaccines.
@en
P2093
P1433
P1476
Randomised controlled trial of ...... e Study of Pertussis Vaccines.
@en
P2093
H O Hallander
L Gustafsson
P304
P356
10.1016/S0140-6736(97)06508-2
P407
P577
1997-11-01T00:00:00Z